CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5,033 enrolled
Drug / intervention
TB screening Questionnaire +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02053129
NCT02053129N/ACompleted

Pilot Evaluation of Pulmonary Tuberculosis Screening in Antenatal Clinics in Lusaka, Zambia

University of North Carolina, Chapel Hill·interventional·Posted Feb 3, 2014·Updated Sep 15, 2017

In Brief

A clinical study evaluating TB screening Questionnaire and Sputum smear and culture (only in HIV negative women who are symptomatic) for Pulmonary Tuberculosis. Completed, enrolled 5,033 participants across 1 site.

Detailed Summary

This is a pilot pulmonary TB screening program done in three antenatal care clinics in Lusaka, Zambia to determine the prevalence of culture-confirmed pulmonary tuberculosis and to determine the sensitivity and specificity of symptom-based TB screening.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesZambia

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2014
Enrollment StartNov 1, 2011
Primary CompletionOct 1, 2012
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.4 years ago

Interventions

TB screening Questionnaireother

All subjects will be screened with the questionnaire which assesses TB symptoms.

Sputum smear and culture (only in HIV negative women who are symptomatic)other

specimens for sputum microscopy and culture collected and processed in accordance with WHO TB Infection Control Guidelines